Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 41 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysisBlair, I.; Williams, K.; Warraich, S.; Durnall, J.; Theong, A.; Manavis, J.; Blumbergs, P.; Vucic, S.; Kiernan, M.; Nicholson, G.
2001Effect of global system for mobile communication (GSM)-like radiofrequency fields on vascular permeability in mouse brainFinnie, J.; Blumbergs, P.; Manavis, J.; Utteridge, T.; Gebski, V.; Swift, J.; Vernon-Roberts, B.; Kuchel, T.
1999Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: An ovine head impact modelVan Den Heuvel, C.; Blumbergs, P.; Finnie, J.; Manavis, J.; Jones, N.; Reilly, P.; Pereira, R.
2014Retinal microvascular damage and vasogenic edema produced by Clostridium perfringens type D epsilon toxin in ratsFinnie, J.; Manavis, J.; Casson, R.; Chidlow, G.
2000Upregulation of amyloid precursor protein and its mRNA in an experimental model of paediatric head injuryVan Den Heuvel, C.; Blumbergs, P.; Finnie, J.; Manavis, J.; Lewis, S.; Jones, N.; Reilly, P.; Pereira, R.
2001Investigation of the effects of impacts to different regions of the lamb headFinnie, J.; Van Den Heuvel, C.; Gebski, V.; Manavis, J.; Summersides, G.; Blumbergs, P.
1998Diffuse neuronal perikaryon amyloid precursor protein immunoreactivity in a focal head impact modelVan Den Heuvel, C.; Lewis, S.; Wong, M.; Manavis, J.; Finnie, J.; Blumbergs, P.; Jones, N.; Reilly, P.
2000Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injuryVan Den Heuvel, C.; Finnie, J.; Blumbergs, P.; Manavis, J.; Jones, N.; Reilly, P.; Pereira, R.
1999Traumatic axonal injury in lambs: a model for paediatric axonal damageFinnie, J.; Lewis, S.; Manavis, J.; Blumbergs, P.; Van Den Heuvel, C.; Jones, N.
2005Elevated serum levels of stromal-derived factor-1α are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patientsZannettino, A.; Farrugia, A.; Kortesidis, A.; Manavis, J.; To, L.; Martin, S.; Diamond, P.; Tamamura, H.; Lapidot, T.; Fujii, N.; Gronthos, S.